Monday, November 16, 2026

NASA’s Chandra Finds Source of Star’s Mysterious Outbursts

A composite NASA Chandra X-ray and Sloan Digital Sky Survey (SDSS) optical image of the galaxy NGC 4559 located about 30 million light-years from Earth. The Chandra data shows X-ray point sources represented in purple, and the SDSS data shows the galaxy and foreground and background objects in red and blue. The luminous blue variable and supernova impostor AT 2016blu is in the middle of the small square.

X-ray: NASA/CXC/Univ. of Virginia/M. Aghakhanloo et al.; Optical: SDSS; Image Processing: NASA/CXC/SAO/P. Edmonds

Using NASA’s Chandra X-ray Observatory, astronomers have discovered what is triggering repeated outbursts from a giant, unstable star.

A new study, published Monday in the latest issue of The Astrophysical Journal, details the discovery of a previously hidden companion object that keeps pulling material away from the massive star every 113 days as they orbit one another. This partner is either a stellar-mass black hole, or the dense collapsed core of a massive star called a neutron star.

This is the first X-ray detection of one of this class of erupting stars. It is also the first of these objects found with a black hole or neutron star companion.

The volatile star, known as AT 2016blu, is in the spiral galaxy NGC 4559, located about 30 million light-years from Earth. Astronomers estimate the mass of this star is at least 33 times that of the Sun.

“For 15 years, astronomers have been watching this star get really bright and then dim again on a regular basis,” said Mojgan Aghakhanloo of the University of Virginia in Charlottesville, who led this study. “Until we were able to get Chandra data at the right time, we couldn’t figure out what was making this happen.”

The star AT 2016blu is a type of luminous blue variable, which are hot, massive stars characterized by changes in brightness. Eta Carinae, for example, is a particularly well-known luminous blue variable.) AT 2016blu is a special type of luminous blue variable that undergoes rapid and repeated increases in brightness. The spikes in brightness are so extreme that they resemble supernova explosions, where a massive star collapses onto itself and material then hurtles outward into space. However, unlike in a supernova explosion, the star is not destroyed, so AT 2016blu is also referred to as a “supernova impostor.”

Between 2012 and 2026, astronomers detected at least 27 bursts of optical light, or light in wavelengths that are visible to our eyes, from AT 2016blu roughly every 113 days.

“This star’s behavior was confusing at first because it kept acting like a supernova, but clearly it’s not because it keeps surviving these outbursts about three times a year,” said co-author Núria Torres-Albà, also of the University of Virginia. “To understand the cause of these eruptions, we realized we needed X-ray data, timed so that we’d observe the star when it was in an outburst.”

The team used Chandra because it is the only X-ray telescope with sharp enough vision to distinguish AT 2016blu from another nearby bright X-ray source.

Images showing AT 2016blu in outburst and quiescence. The top-left image shows NASA’s Chandra X-ray data obtained in 2001 and 2002 before AT 2016blu’s first observed outburst in 2012, and the bottom-right image shows Chandra data obtained between March 24 and March 27, 2026. Optical data obtained March 14, 2026, by the Katzman Automatic Imaging Telescope (KAIT) is seen in the bottom left when AT 2016blu was in quiescence (not in outburst), and the bottom-right image shows KAIT data from March 25, 2026, when the source was in outburst.

X-ray: NASA/CXC/Univ. of Virginia/M. Aghakhanloo et al; Optical: NSF/KAIT

“We suspected that the bright repeating flashes at optical wavelengths might actually be powered by periodic blasts of high-energy X-rays,” said co-author Nathan Smith of the University of Arizona in Tucson. “The dense gas surrounding the system is heated by the X-rays and then glows in the optical. So, we needed to plan the Chandra X-ray observations carefully to be simultaneous with an optical outburst.”

Chandra data from March 2026 revealed that AT 2016blu was at least 100 times brighter in X-rays than in Chandra data from 2001 to 2002, which is before the outbursts began. The best explanation for this is that material from the star is falling onto a neutron star or black hole during the closest approach in their oval-shaped orbit around one another. When they come close together, material ejected by the star gets captured by the black hole or neutron star. The material orbits at very high speeds close to the speed of light, getting so hot that it shines brightly in X-rays.

AT 2016blu is bright enough in X-rays to be classified as a candidate of ultra-luminous X-ray source. These are rare, bright X-ray sources found with telescopes like Chandra that astronomers have yet to fully understand. Scientists’ current thinking is that some of them contain neutron stars, and others have black holes.

These new observations suggest there could be a link between ultra-luminous X-ray sources and the kind of violent stellar eruptions seen in AT 2016blu, especially because many ultra-luminous X-ray sources undergo large changes in X-ray brightness.

The discovery of this system may also help studies of stars that change in brightness before they undergo supernova explosions. Astronomers suspect that much of this behavior may be caused by systems containing a massive star orbiting a compact object or another massive star.

To collect the optical data, the team used the Katzman Automatic Imaging Telescope, the Las Cumbres Observatory Global Supernova Project , and observations from the American Association of Variable Star Observers, including those from more than 30 amateur astronomers, to monitor the star’s brightness.

When these observations showed that the star was in outburst in early 2026, Chandra observations were triggered and obtained in March 2026 as part of its “Target of Opportunity” program designed to take account of special events.

NASA's Marshall Space Flight Center in Huntsville, Alabama, manages the Chandra program. The Smithsonian Astrophysical Observatory's Chandra X-ray Center controls science operations from Cambridge, Massachusetts, and flight operations from Burlington, Massachusetts.

To learn more about Chandra, visit: https://nasa.gov/chandra

Visual Description

This release features a composite image of a spiral galaxy with a giant, unstable star at its outer edge. Using Chandra, astronomers have discovered the star's previously hidden companion, which triggers luminous outbursts every 113 days.

The spiral galaxy is NGC 4559. Shown at a sharp angle in the composite image, its flat pink and milky blue face tilts toward our upper left. Sitting near the outer edge of the dense spiral, near the center of the frame, is a small group of pink and blue dots. This group is outlined with a white square, enlarged and annotated in supporting images.

The smallest pink dot in the square is AT 2016blu, a massive star some 33 times the mass of our Sun. For over 15 years astronomers have been watching this star get bright and then dim again in optical light on a regular basis. Chandra's X-ray observations suggest that a hidden companion object, either a stellar mass black hole or a neutron star, is pulling material from AT 2016blu every 113 days as they orbit one another. This captured material gets so hot that it shines brightly in X-rays.

Other pink and blue specks within the white square and enlargement are unresolved stars or star clusters, too distant to be related to the movement of material between AT 2016blu and its hidden but influential neighbor. 

Source: NASA’s Chandra Finds Source of Star’s Mysterious Outbursts - NASA Science 

Arginine and the Immune System: How One Amino Acid May Help Cells Flag Cancer and Viruses

Arginine is an amino acid your body makes and also gets from protein-rich foods. A new study from Rockefeller University suggests that when arginine runs low, cells lose some of their ability to show the immune system what is going on inside them. In mice, restoring arginine through the diet reduced colon tumors and eased viral infections. The work was published in Cell.

The starting point: arginine runs low in disease

Low arginine is associated with several diseases, including colon cancer. The lab of Sohail Tavazoie had already shown in 2023 that starving colon cancer cells of arginine increases the number of mutations they accumulate. First author Qiushuang Wu then asked a broader question: can changes in arginine, caused by diet or disease, alter gene expression? She looked at colon cancer, influenza and SARS-CoV-2, all of which have documented shifts in amino acid levels. In all of these conditions, arginine turned out to be the most depleted amino acid.

What goes wrong when arginine is scarce

In cell cultures, low arginine left 414 proteins abnormally scarce. The standout was MHC-1 (major histocompatibility complex class I). These proteins sit on the surface of cells throughout the body and display fragments of what is inside, so T cells can spot a mutated cell or a virus-infected one and call in other immune cells.

The reason is mechanical. MHC-1 is built from many arginine codons, the three-letter DNA “words” that specify arginine. In an arginine-poor environment, ribosomes, the machines that assemble proteins, stalled while trying to translate MHC-1. Fewer MHC-1 proteins reached the cell surface, which gave cancerous or infected cells a better chance to escape notice.

What happened in mice

·         Colon cancer: mice on a low-arginine diet developed more colon tumors, while mice given more arginine developed fewer.

·         Influenza: mice on an arginine-rich diet had milder symptoms. Giving arginine after infection also improved outcomes, which the researchers described as very surprising.

·         SARS-CoV-2: the same overall pattern held in a COVID-19 mouse model, with the infection experiments run in collaboration with Charles Rice’s lab.

The press release also says a moderate dose of arginine, comparable to a couple of over-the-counter tablets, could potentially rescue expression of the genes needed to make MHC-1.

Reading the headlines carefully

Some coverage calls this a “simple supplement” for fighting cancer and viruses. The study itself is more modest:

·         It is preclinical. The animal results come from mice on controlled diets. They do not show that arginine pills prevent or treat cancer or infections in people.

·         The authors call for trials. Tavazoie says arginine supplementation could be readily tested in patients receiving immunotherapies or in high-risk groups exposed to viruses. That is a proposal for future studies, not a result.

·         The ideas about aging are interpretation. The team suggests that falling arginine with age, along with poor diet, could contribute to colon cancer and to greater mortality from respiratory viruses. That is a hypothesis built on these findings, not something they tested directly.

Anyone considering supplements for a health condition should talk to a doctor or pharmacist first, since this study gives no basis for dosing or self-treatment.

Why it matters

Beyond arginine itself, the study shows that the amount of a single amino acid in the diet can tune how strongly a protein enriched in that amino acid is produced. Tavazoie suggests this kind of dietary tuning of gene expression probably extends to other proteins and amino acids, and his team is now testing other amino acids in different disease settings. If it holds up, nutrition could become a tool that works alongside existing therapies, which is exactly what the next round of studies will need to test.

Sources

·         Press release: Rockefeller University, “The amino acid arginine helps the body fight tumors and viral infections” (July 30, 2026) – rockefeller.edu

·         Paper: Wu Q. et al., “Dietary arginine drives codon-dependent MHC-I translation and improves immunity in colon tumorigenesis and respiratory viral infection,” Cell, 2026 – cell.com (DOI: 10.1016/j.cell.2026.07.020)

Source: Arginine and the Immune System: How One Amino Acid May Help Cells Flag Cancer and Viruses